Timing is everything for Rakon in AI
Markets

Timing is everything for Rakon in AI

It spent almost $3 million on failed takeover offer.

Rakon to face shareholders on failed takeover
Markets

Rakon to face shareholders on failed takeover

Updated: Rakon warns of lower revenues. 

Neuren expects $150 million in US royalties
Markets

Neuren expects $150 million in US royalties

Its groundbreaking Rett Syndrome treatment was approved in 2023.

Partial takeover target Vital posts small profit
Markets

Partial takeover target Vital posts small profit

The business telco provides services including fibre and mobile.